Login
Companies $OBIO
$7.12 +$0.00 (0.0%) After hours
Orchestra BioMed Holdings, Inc. logo

Orchestra BioMed Holdings, Inc.

orchestrabiomed.com

What Do They Do?

Develops a pacemaker-delivered hypertension therapy and a drug-delivery balloon for medical-device partners treating cardiovascular disease.

How Do They Make Money?

Partners pay upfront for rights and development agreements; FreeHold sells intracorporeal organ retractors.

revenue
SegmentShareRevenue
Partnership revenue
Sold outright

98%
FY2022: 81%
Product revenue
Sold outright
1.8%
FY2022: 19%

Who Are Their Customers?

Partners with established medical-device companies on development and commercialization; its FreeHold subsidiary also sells intracorporeal organ retractors.

Do Revenues Turn Into Profits?

No. It lost $52.7M in FY2025.

Operating income, FY2025
−155% of revenue
▲ +19% (Loss) vs FY2024 (−$64.3M, −2437%)
Net income, FY2025
−157% of revenue
▲ +14% (Loss) vs FY2024 (−$61M, −2313%)
Free cash flow, FY2025
−148% of revenue
▲ +3% (Loss) vs FY2024 (−$50.8M, −1927%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −89%
vs $861K in Q3 FY2025
Net income
▲ +10% (Loss)
vs −$20.8M in Q3 FY2025

Business focus The earlier report described a blank-check company seeking a healthcare-innovation business combination; the latest report describes a business developing hypertension and artery-disease therapies with medical-device partners.

Revenue over time
Partnership revenue Product revenue
$50M$25M$0

Who Do They Compete With?

Competes with Boston Scientific, Medtronic, Becton Dickinson, Philips, B. Braun, Abbott Laboratories, Cordis, Teleflex, Concept Medical, MicroPort, Eurocor Tech, iVascular, Biosensors International Group, Balton, Invamed, BIOTRONIK, and MicroPort CRM

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support